GlassScriptPhysician profile
Aimee S Sandifer
NPI 1912959271
$1,214.10
in general payments reported to CMS, 2019-2025
18 companies · $49.79 in 2025
The $49.79 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $325 · 2023: $451 · 2024: $149 · 2025: $49.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.79 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $168.52 | 2021-2024 | |
| Astellas Pharma US INC | $143.16 | 2023-2025 | Veozah |
| Myriad Women'S Health, INC. | $137.32 | 2023 | Myrisk |
| Abbvie INC. | $119.27 | 2021-2025 | |
| Daiichi Sankyo INC. | $112.56 | 2021-2023 | Injectafer |
| Organon LLC | $106.06 | 2021-2024 | Nexplanon |
| Evofem Biosciences, INC. | $100.88 | 2021-2024 | Phexxi |
| Smith+Nephew, INC. | $60.50 | 2021-2023 | Stravix Pl, Stravix |
| Avion Pharmaceuticals | $55.90 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $48.21 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $36.03 | 2022-2023 | Ultomiris |
| Exeltis, USA INC. | $31.39 | 2021-2022 | |
| Hologic Sales and Service, LLC | $25.52 | 2024 | Novasure |
| Lilly USA, LLC | $16.35 | 2025 | Zepbound |
| Novo Nordisk INC | $16.34 | 2023 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.54 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $11.42 | 2021 | |
| Merck Sharp & Dohme LLC | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Sandifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.